1 / 7

Statistics about snake bite syndromes and outcomes

Statistics about snake bite syndromes and outcomes. CMC Vellore 11.3.13. Data. Data from November 2011 – 2012 Total cases – 48 Clinical syndromes Non venomous – 3 (6%) Venomous Neurotoxic:14 (29%) Heamatotoxic:7 (14%) Combined: 24 (50%). Management strategies.

cadman-mckinney
Download Presentation

Statistics about snake bite syndromes and outcomes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Statistics about snake bite syndromes and outcomes CMC Vellore 11.3.13

  2. Data • Data from November 2011 – 2012 • Total cases – 48 • Clinical syndromes • Non venomous – 3 (6%) • Venomous • Neurotoxic:14 (29%) • Heamatotoxic:7 (14%) • Combined: 24 (50%)

  3. Management strategies • Premedication:no adrenaline prior to ASV • Supportive medications: • Neostigmine – 3 (6%) • Antibiotic • Amoxycillin clavulunate • Cellulitis

  4. ASV dosing • Indications • Neurotoxic: progressing neuromuscular paralysis • Heamatotoxic: deranged bleeding parameters and clinical bleeding. • ASV dose • Neurotoxic: 10 vials • Heamatotoxic – 8 – 26 vials

  5. Adverse reactions to ASV • Minor – itching and utricaria • 5 (10.4%) • Major – anaphylaxis • 2 (4.1%)

  6. Outcomes • Mechanical ventilation: 11 (22.9%) • Heamodialysis : 6 (12.5%) • Deaths : 0

  7. Snakes identified • In 3 situations • 6%

More Related